Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.9600
+0.0282 (3.03%)
At close: Jun 18, 2026, 4:00 PM EDT
0.9440
-0.0160 (-1.67%)
After-hours: Jun 18, 2026, 7:45 PM EDT
Oncolytics Biotech Employees
Oncolytics Biotech had 29 employees as of December 31, 2025. The number of employees increased by 1 or 3.57% compared to the previous year.
Employees
29
Change (1Y)
1
Growth (1Y)
3.57%
Revenue / Employee
n/a
Profits / Employee
-$1,147,966
Market Cap
114.58M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 29 | 1 | 3.57% |
| Dec 31, 2024 | 28 | -1 | -3.45% |
| Dec 31, 2022 | 29 | 3 | 11.54% |
| Dec 31, 2021 | 26 | 1 | 4.00% |
| Dec 31, 2020 | 25 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Alps Group | 93 |
| enGene Therapeutics | 82 |
| Agenus | 81 |
| Pyxis Oncology | 56 |
| PepGen | 56 |
| Jyong Biotech | 27 |
| Cognition Therapeutics | 14 |
| Coya Therapeutics | 8 |
ONCY News
- 2 days ago - Oncolytics secures new patent for pelareorep manufacturing - TheFly
- 2 days ago - Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044 - GlobeNewsWire
- 14 days ago - Oncolytics Biotech Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 16 days ago - Oncolytics promotes John McAdory to COO - TheFly
- 16 days ago - Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer - GlobeNewsWire
- 17 days ago - Oncolytics announces initial data from pelareorep combination study - TheFly
- 17 days ago - Oncolytics Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches - GlobeNewsWire
- 17 days ago - Oncolytics Biotech Slides: Investor presentation - Filings